Basf Corp, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IBUPROFEN DC 85, with a corresponding US DMF Number 20421.
Remarkably, this DMF maintains an Active status since its submission on April 09, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 04, 2013, and payment made on August 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II